CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells

This publication has 10 references indexed in Scilit:

• The unique sensitivity of Walker rat tumour cells to difunctional agents is associated with a failure to recover from inhibiton of DNA synthesis and increased chromosome damage
  Mutation Research/DNA Repair Reports, 1986
• Walker rat carcinoma cells are exceptionally sensitive to cis-diamminedichloroplatinum(II) (cisplatin) and other difunctional agents but not defective in the removal of platinum-DNA adducts
  Mutation Research/DNA Repair Reports, 1986
• CB 1954 revisited
  Cancer Chemotherapy and Pharmacology, 1986
• Quantitative aspects of the formation and loss of DNA interstrand crosslinks in Chinese hamster cells following treatment with cis-diamminedichloroplatinum(II) (cisplatin) II. Comparison of results from alkaline elution, DNA renaturation and DNA sedimentation studies
  Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1981
• Selective inhibition of ribonucleotide reductase by the monofunctional alkylating agent 5(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954)
  Biochemical Pharmacology, 1980
• Protection against the effects of the antitumour agent CB 1954 by certain imidazoles and related compounds
  Biochemical Pharmacology, 1975
• Studies on the reversal of the selective antitumour effect of the aziridinyl derivative cb 1954 by 4‐amino‐5‐imidazolecarboxamide
  International Journal of Cancer, 1972
• Quantitative aspects of the repair of alkylated DNA in cultured mammalian cells
  Chemico-Biological Interactions, 1971
• Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the walker tumour
  International Journal of Cancer, 1971
• 2,4-Dinitro-5-ethyleneiminobenzamide (CB 1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256
  Biochemical Pharmacology, 1969